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Objective To assess the usefulness of the general framework of the smoking epidemic.
Methods We use lung cancer mortality as an indicator for smoking intensity and employ an age–cohort model to accommodate the
long-lasting and cumulative effects.
Results Dutch males have higher risks than Danish males, but the risks for the younger cohorts have been declining faster in the
Netherlands than in Denmark. Danish women have about twice the risk of Dutch women, and in both countries the risks for the younger
cohorts are increasing. The smoking epidemic began at about the same time in Denmark and the Netherlands. Dutch males, however,
seem to have smoked more but to have given up smoking more quickly than Danish males. Danish females were quicker to take up
smoking than Dutch females.
Conclusions Within the general framework of the smoking epidemic, differences in timing and levels can produce large differences
between countries. For the purposes of assessing smoking-related risks, including projections, the smoking epidemic framework
therefore has to be tailored to each study population.
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Introduction
Research on the health effects of smoking has revealed not just
that smoking is a risk factor for a large and still increasing
number of diseases but also that its ill effects seem to be
cumulative and long-lasting (1, 2). The risk of contracting at
least some of the diseases associated with smoking increases
with the duration of exposure. Quitting decreases the risk, but
for some diseases, e.g. lung cancer and chronic obstructive
pulmonary disease, it does so only very slowly. Consequently,
current exposure is not a very good indicator of current and
future risks, and past exposure should be taken into account as
well.
A good indicator of such risks would capture lifelong
exposure and, preferably, changes in the amounts smoked and
the composition of cigarettes. Although for many developed
countries smoking prevalences are available since the 1960s,
i.e. soon after the risks were officially recognized, data on
amounts smoked and on cigarette composition are muchmore
scarce. Data on smoking exposure before 1960 are largely
anecdotal.
This lack of data has prompted some authors to argue
that, in developed countries, lung cancer was overwhelmingly
caused by smoking, and that mortality from lung cancer was
therefore a good indicator of smoking intensity, defined as the
total accumulated risk. Smoking intensity, estimated in this
way, was then used to estimate the risk for other smoking-
related diseases and to make projections of future risks (3, 4).
In a semiquantitative analysis of data from developed
countries, Lopez et al. (5) derived the typical shape of the
smoking epidemic. On a time scale of 100 years, men start to
smoke, reach exposures exceeding 60% after about 50 years,
and stay at this high level for some 20 years. Exposure then
declines gradually, stabilizing at about 30%. Women start to
smoke about 20 years after men and reach exposure levels of
up to about 40%. Their exposure begins declining at almost the
same time as in men. Eventually, the prevalences for women
and men converge at the 30% level. The mortality attributable
to smoking lags its prevalence by some 40 years .
Such a general theory of the evolution of the smoking
epidemic would be very useful as a contribution not only to
understanding the current burden of disease caused by
smoking but also to projecting the future burden. Before it
can be deployed, however, it should be compared with
empirical data in order to test whether it is applicable in specific
circumstances.
It is appropriate to use lung cancer mortality as an
indicator for past smoking because very long periods of time
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are under consideration (3). However, a smoking epidemic
shaped as Lopez et al. (5) hypothesized would have affected
subsequent birth cohorts differently. Differences between
cohorts and the cumulative character of the risk for lung cancer
call for an analysis of lung cancer mortality in terms of cohort
smoking intensities. We report such an analysis for Denmark
and the Netherlands, show the similarities and differences
between the two countries, and make inferences about their
respective smoking epidemics and the implications for a
general theory of smoking epidemics.
Data and methods
Lung cancer mortality and population data in the Netherlands,
by sex and five-year age group, for the period 1950–97 were
obtained from Statistics Netherlands. For the period 1950–69
the oldest age group was585 years and subsequently it was
595 years. Data onmortality attributable to lung cancer by sex
and age in Denmark for the period 1943–96 were obtained
from the National Institute of Public Health. For both
countries we used deaths of persons aged530 years.
Table 1 shows the classification systems and codes used
over these periods. For International Classification of Diseases
revisions 6–9 (ICD-6–9), code 162was used; for ICD-10, code
C34 was used. In the Dutch data , for ICD-6 and ICD-7 many
lung cancer deaths were coded 163, whereas, starting with
ICD-8 (1969), code 163 was reserved for mesothelioma. For
ICD-6 and ICD-7, therefore, we took code 163 in addition to
code 162. For purposes of comparability we used the same
procedures for Denmark, although very few cases were coded
163 in this country.
An age–cohort model with five-year age groups was
fitted to each data set. In the log-linear regression analysis the
annual age-specific death rates were assumed to be composed
of a basic age-specific ratemultiplied by relative risks specific to
birth cohorts (see Box 1). The basic rate and the cohort-
specific relative risks were estimated separately for the two
countries.
To make the analysis comparable between the two
countries, the parameters for the 5-year age groups in
Denmark were estimated on the 1-year age group data. In
both countries the age groups did not fully coincide with
particular birth cohorts, and interpolation was therefore used
to estimate the relative contributions of adjacent birth cohorts
to the death rates in particular years. The interpolation
weighted the cohort-specific risk by the number of person-
years in the birth cohorts.
Results
The estimated parameter values of the regression are shown
with the age-specific mortality rate of the 1918–22 baseline
cohort in Table 2 and with the cohort-specific relative risks in
Table 3. The goodness-of-fit criteria (scaled deviance) are also
shown in Table 2. The Danish values are much higher than the
Dutch because the Danish data give age at death, while the
Dutch data are partitioned in five-year age groups. The degrees
of freedom in the Danish analysis are correspondingly much
higher than those in the Dutch analysis.
Fig. 1 and Fig. 2 show observed and fitted lung cancer
mortality rates for men and women, respectively. Rates by
calendar year for the period 1943–97 for six age groups are
given. The mortality rates for men are much higher than those
for women. For all age groups, mortality rates for Dutch males
were 50–60% higher than those for Danish males throughout
the period, while the rates for Danish females are two to three
times higher than those of Dutch females.
For males the effect of the smoking epidemic on lung
cancer has clearly peaked. Male mortality rates in Denmark are
on a plateau. Among Dutch males, particularly in the younger
age groups, mortality rates are declining, albeit slowly. For
females the opposite is true: mortality rates are increasing
sharply in bothDenmark and theNetherlands, and only among
Danish women aged 55–59 years is there a suggestion of
stabilization during the most recent years.
Fig. 3 and Fig. 4 show the relative risks of lung cancer
mortality in each birth cohort (antilogs of b
c
, see Box 1) of men
and women, respectively. The numbers are rescaled such that
the 1878–82 cohort equals 1. The levels of relative risk are not
comparable between Denmark and the Netherlands because
the analyses were performed separately for each country.
However, the shapes of the curves are comparable.
For men the increase in relative risk among the oldest
cohorts is very similar, but for the cohort of 1903–07 and
subsequent cohorts the relative risk stabilizes in Denmark,
while in the Netherlands the relative risk begins to decline
Box 1. Age-cohort model fitted to data
yaˆ,j = Na,j exp (aa + Sc bc pa,j,c ); y follows a Poisson distribution.
Where:
yaˆ,j is the expected number of deaths in age group a in year j ;
Na,j is the number of person-years at risk in age group a in year j ;
aa is ln(risk in age group a in baseline cohort);
bc is ln(relative risk of cohort c relative to baseline cohort);
pa,j,c is fraction of person-years at risk in age group a in year j
belonging to cohort c (baseline cohort excluded).
This log-linear model was fitted using maximum likelihood estimation
with the GLIM program (6). The goodness-of-fit was assessed using the
likelihood-ratio criterion (scaled deviance) based on Poisson deviates.
Cohorts from before 1867 and after 1958 were combined because of
small numbers.
Clayton & Schifflers observe that the parameters a and b of such a
model are not identifiable because it is possible to obtain the same
expected number of deaths from an infinite number of pairs of a and b
values by subtracting a constant from one and adding it to the other (7).
We followed the convention of resolving this parameterization problem
by arbitrarily setting the relative risk of a baseline cohort (the 1918–22
cohort) at 1, and expressing the risk of all other cohorts relative to this
cohort. The a values could then be interpreted as age-specific rates,
and the b values as relative risks (7).
Table 1. Classification systems and codes used for lung cancer




Denmark 1943–50 Bertillon 716
1951–68 ICD-6/7 162, 163
1969–93 ICD-8 162
1994–96 ICD-10 C34
Netherlands 1950–68 ICD-6/7 162, 163
1969–95 ICD-8/9 162
1996–97 ICD-10 C34
a ICD = International Classification of Diseases. Denmark never used ICD-9.
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Table 2. Goodness-of-fit criterion (scaled deviance) with degrees of freedom, estimated a values of regression model, standard
errors and age-specific rates for baseline cohort 1918–22, males and females, the Netherlands and Denmark
Netherlands Denmark
Males Females Males Females
Scaled
deviance
1759 810 5295 4497
Degrees
of freedom











30–34 –10.900 0.0617 0.0184 –13.180 0.0932 0.0019 –11.350 0.1121 0.0117 –12.180 0.1267 0.0051
35–39 –9.699 0.0341 0.0613 –11.930 0.0615 0.0066 –10.200 0.0633 0.0372 –11.030 0.0765 0.0162
40–44 –8.664 0.0213 0.1727 –10.990 0.0473 0.0169 –9.087 0.0379 0.1131 –10.040 0.0522 0.0434
45–49 –7.763 0.0150 0.4250 –10.060 0.0381 0.0426 –8.133 0.0256 0.2937 –9.039 0.0373 0.1186
50–54 –6.978 0.0118 0.9324 –9.332 0.0330 0.0885 –7.257 0.0190 0.7051 –8.361 0.0308 0.2337
55–59 –6.312 0.0101 1.8138 –8.710 0.0299 0.1649 –6.544 0.0157 1.4387 –7.653 0.0261 0.4746
60–64 –5.767 0.0093 3.1296 –8.151 0.0277 0.2886 –5.993 0.0142 2.4961 –7.132 0.0237 0.7993
65–69 –5.328 0.0090 4.8529 –7.688 0.0267 0.4582 –5.563 0.0135 3.8363 –6.615 0.0219 1.3406
70–74 –5.008 0.0089 6.6876 –7.314 0.0256 0.6660 –5.247 0.0134 5.2622 –6.251 0.0214 1.9294
75–79 –4.772 0.0095 8.4597 –6.959 0.0279 0.9502 –5.055 0.0153 6.3753 –5.982 0.0250 2.5228
80–84 –4.664 0.0112 9.4248 –6.717 0.0321 1.2102 –5.004 0.0186 6.7102 –5.863 0.0303 2.8428
85–89 –4.651 0.0145 9.5551 –6.541 0.0369 1.4424 –5.051 0.0266 6.4055 –5.750 0.0389 3.1834
5 90 –4.705 0.0244 9.0503 –6.375 0.0488 1.7033 –5.312 0.0535 4.9299 –5.857 0.0642 2.8603
a SE = standard error.
Table 3. Estimated b values of regression model, standard errors and relative risks for cohorts from before 1867 to after 1958,
relative to baseline cohort 1918–22, males and females, the Netherlands and Denmark
Netherlands Denmark
Males Females Males Females
Cohort effect b SE a RR b b SE RR b SE RR b SE RR
41867 –2.327 0.1135 0.0976 –1.523 0.1681 0.2180 –2.979 0.1134 0.0508 –2.674 0.1312 0.0690
1868–72 –2.093 0.0703 0.1233 –1.499 0.1281 0.2234 –2.259 0.0682 0.1045 –2.302 0.1006 0.1001
1873–77 –1.730 0.0389 0.1772 –1.153 0.0807 0.3156 –1.949 0.0450 0.1425 –1.902 0.0667 0.1492
1878–82 –1.388 0.0260 0.2496 –1.124 0.0628 0.3250 –1.667 0.0340 0.1888 –1.840 0.0554 0.1589
1883–87 –1.111 0.0194 0.3292 –1.072 0.0529 0.3423 –1.227 0.0258 0.2931 –1.607 0.0451 0.2004
1888–92 –0.732 0.0154 0.4811 –1.014 0.0467 0.3627 –0.852 0.0213 0.4268 –1.435 0.0393 0.2382
1893–97 –0.318 0.0128 0.7278 –0.918 0.0411 0.3993 –0.510 0.0182 0.6006 –1.296 0.0348 0.2735
1898–02 –0.113 0.0116 0.8932 –0.787 0.0376 0.4552 –0.262 0.0166 0.7697 –1.118 0.0314 0.3269
1903–07 0.049 0.0111 1.0505 –0.692 0.0357 0.5007 –0.115 0.0157 0.8918 –0.914 0.0289 0.4010
1908–12 0.104 0.0103 1.1092 –0.552 0.0329 0.5760 –0.084 0.0153 0.9199 –0.656 0.0267 0.5191
1913–17 0.061 0.0122 1.0631 –0.321 0.0372 0.7257 –0.112 0.0163 0.8945 –0.378 0.0266 0.6855
1918–22 NAc NA 1.0000 NA NA 1.0000 NA NA 1.0000 NA NA 1.0000
1923–27 –0.106 0.0140 0.8999 0.348 0.0370 1.4164 –0.048 0.0185 0.9534 0.251 0.0272 1.2857
1928–32 –0.080 0.0135 0.9230 0.823 0.0328 2.2776 –0.051 0.0214 0.9504 0.575 0.0292 1.7771
1933–37 –0.181 0.0177 0.8348 0.870 0.0398 2.3871 –0.147 0.0276 0.8633 0.685 0.0347 1.9830
1938–42 –0.396 0.0237 0.6728 1.085 0.0452 2.9581 –0.328 0.0384 0.7202 0.626 0.0446 1.8707
1943–47 –0.354 0.0308 0.7022 1.313 0.0521 3.7158 –0.190 0.0478 0.8269 0.657 0.0557 1.9291
1948–52 –0.455 0.0469 0.6342 1.497 0.0667 4.4701 –0.285 0.0824 0.7523 0.666 0.0862 1.9461
1953–57 –0.659 0.0828 0.5175 1.787 0.0917 5.9695 –0.338 0.1460 0.7133 0.831 0.1354 2.2964
51958 –0.873 0.1352 0.4176 1.903 0.1257 6.7062 –0.523 0.2716 0.5930 0.051 0.3104 1.0522
a SE = standard error.
b RR = relative risk.
c NA = not applicable.
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slowly. This happens in Denmark only with the 1933–37
cohort or the 1938–42 cohort. Consistently, Fig. 1 shows that
Dutch mortality rates have clearly declined in recent years but
thatDanishmortality rates seem to have stabilized for themost
part.
For women the picture is quite different (Fig. 4). The
relative risks start to rise much later than those for men, and
there is a marked difference between the two countries: the
increase begins some 20 years later in Denmark and about 30
years later in the Netherlands. No declines are yet visible. The
Danish relative risks seem to stabilize as from the 1933–37
cohort, the increase visible for the youngest cohorts not being
statistically significant. The Dutch relative risks are rising
relentlessly. Again this is consistent with the results in Fig. 2:
the rates in both countries are increasing in all age groups
except for the possible recent stabilization in the youngest
Danish group.
Discussion
Denmark and the Netherlands are both confronted with the
late effects of a smoking epidemic that goes back many
decades. There are similarities in this matter between the two
countries but there are also striking differences.
For the analysis of the lung cancer data we looked at age–
period models, age–cohort models, and age–period–cohort
models. Age is always needed in the models because lung
cancer mortality is clearly related to age. We chose an age–
cohort model because lifelong smoking exposure seemed to be
decisive for the level of risk. For both countries the age–cohort
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model produced a fit that was reasonable andmuch better than
that of the age–period model. Nevertheless, for males,
particularly in the Netherlands, the age–cohort model seemed
to overestimate systematically for the most recent years
(Fig. 1).
We explained this by the sharp declines in male smoking
prevalence across age groups since 1970 which, despite the
long lag times, were beginning to have a beneficial effect. We
could have improved the fit of the model and lowered the
scaled deviance by including a period effect so as to capture the
effects of quitting smoking. We decided against this because
the improvement of the fit would have been small and would
not have outweighed the identification problem of a full age–
period–cohort model, which poses fundamental difficulties in
the interpretation of the parameter estimates (8).
Our results can be readily interpreted in the framework
of the smoking epidemic as proposed by Lopez et al. (5). Dutch
andDanish males started to smoke at about the same time, but
Dutchmales smokedmore, per capita or as a percentage of the
population, or both. However, Dutch males evidently started
to quit earlier and in greater numbers than their Danish
counterparts, causing the rates for the younger age groups in
recent years to fall again, while the Danish rates are mostly
stable.
Danish women were quicker to follow the example of
the men than Dutch women, and this shows up in the much
higher lung cancer mortality among the former. However, it is
likely that Dutch women will eventually catch up with Danish
women in this respect, given the stagnation of relative risks in
recent Danish birth cohorts but not in Dutch cohorts (Fig. 4).
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While time series data on smoking prevalences must be
interpreted with caution, they seem to support this interpreta-
tion. The oldest Dutch data are from 1958, when 90% of
Dutch males were reported to be smokers (9). The prevalence
of smoking amongDanishmales was reported to be somewhat
lower, at around 80%, in 1953–54 (10). In 1986–87, however,
Dutch male smoking exposure was down to 41% while the
corresponding value inDenmark was still 49%. In 1990–91 the
prevalence for the Netherlands and Denmark was 39% and
47%, respectively (10, 11).
By contrast, in 1953–54 a total of 40% ofDanish women
smoked , while in 1958 the corresponding proportion was 29%
ofDutchwomenThe prevalence of smokingwas lower among
all age groups in the Netherlands, but was particularly
so among women aged over 50 years. In Denmark this
level remained at 40% in 1985–87 and 1990–91, although
there were increases among women aged over 40 years
and decreases among those younger than this. Overall
exposure in the Netherlands increased to 34% in 1985–87
but fell again to 31% in 1990–91. Here too there was a shift
towards older ages (9–11).
We conclude that, while both Denmark and the
Netherlands fit within the concept of the smoking epidemic,
there still are considerable differences. Fig. 3 shows that the
part of the epidemic affecting males began at about the same
time in both countries. Subsequently, much higher smoking
intensities developed among Dutch males than their Danish
counterparts (Fig. 1). The epidemic began to affect Danish
females after a much shorter time lag than the Dutch females
(Fig. 4). We interpret the difference between Dutch and
Danish males as being mostly attributable to a difference in the
level of the epidemic, and the difference between Dutch and
Danish females as being a matter of timing and, judging by the
smoking prevalence data, of level.
The age–cohort model employed in this analysis could be
used for extrapolation. The extrapolation of the current fitted
models could permit mortality to be determined with reference
to the relative risks of the youngest cohorts in Figs. 3 and Fig. 4.
The drawback is that these relative risks would be based on small
numbers of deaths in the youngest age group considered.
Furthermore, predictions would be based only on lung
cancer mortality, even though other data could be taken into
account. Developments in the prevalence of smoking over the
last 30 years or so could be considered since the decline
observed in both countries seems to be coming to an end.
There is also themore general notion of the smoking epidemic,
linking the current rise in female lung cancer mortality to the
rise in the prevalence of smoking that occurred after the
Second World War.
For themoment, however, the conceptual framework of
the smoking epidemic is mostly suitable for descriptive
purposes, because differences in timing and levels can produce
large differences between countries. For the concept to lend
itself to projection it should be tailored to particular
populations. A Baysean approach might be useful here. The
framework of the smoking epidemic could be regarded as the
prior distribution, to be updated using cohort smoking
intensities estimated through lung cancer mortality in relation
to long-term exposure and developments in smoking
prevalence in relation to more recent exposure.
Pending such a combined approach, certain predictions
can be made. In both countries, mortality attributable to lung
cancer among females is likely to rise rapidly. This can be
deduced partly by extrapolating the trends of the last two
decades. Moreover, it should be noted that, in the age groups
65–69 years, 70–74 years, and 75–79 years, mortality rates are
virtually the same (Fig. 2). Given the age effect on lung cancer,
this means that by the time women aged 65–69 years have
progressed to older age groups their mortality will be higher
than the current rates for these older age groups. In Denmark
the first sign of stabilization in the longer termmay be visible in
the relative risks for the youngest cohorts and the most recent
rates for the 55–59-year age group, but in the Netherlands
there are no such indications.
The outlook for men is better, although it should be
remembered that mortality remains far higher among males
than among females. The decline in relative risks among the
more recent male cohorts suggests that the fall in lung
cancer mortality observed in the younger age groups will
eventually extend to the older ones. For the moment this
development is more pronounced in the Netherlands than
in Denmark.
As more results from smoking studies become available,
the smoking-related burden of disease keeps increasing, and
awareness of the consequences of the smoking epidemic in the
very long term becomes more acute (12). n
Conflicts of interest: none declared.
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Re´sume´
Comparaison de l’intensite´ du tabagisme dans des cohortes au Danemark et aux Pays-Bas
Objectif Evaluer l’utilite´ du sche´ma ge´ne´ral de l’e´pide´mie de
tabagisme.
Me´thodes Nous avons conside´re´ la mortalite´ par cancer du
poumon comme indicateur de l’intensite´ du tabagisme mais avons
utilise´ un mode`le faisant appel aux cohortes d’aˆge pour tenir
compte des effets durables et cumulatifs.
Re´sultats Parmi les sujets de sexe masculin, les Ne´erlandais ont
un risque plus e´leve´ que les Danois, mais le risque diminue plus
rapidement dans les cohortes jeunes que dans les cohortes plus
aˆge´es. Chez les femmes, le risque est environ deux fois plus e´leve´
chez les Danoises que chez les Ne´erlandaises, et dans les deux pays
le risque est en augmentation dans les cohortes jeunes. L’e´pide´mie
de tabagisme a commence´ a` peu pre`s en meˆme temps au
Danemark et aux Pays-Bas. Les Ne´erlandais semblent toutefois
avoir fume´ davantage que les Danois mais avoir arreˆte´ plus toˆt. Les
Danoises ont arreˆte´ plus toˆt que les Ne´erlandaises.
Conclusion A l’inte´rieur du sche´ma ge´ne´ral de l’e´pide´mie de
tabagisme, des diffe´rences de chronologie et d’intensite´ peuvent se
traduire par d’importantes divergences d’un pays a` l’autre. En ce
qui concerne l’e´valuation des risques lie´s au tabagisme, et
notamment les projections, le sche´ma ge´ne´ral de l’e´pide´mie doit
eˆtre adapte´ a` chaque population e´tudie´e.
Resumen
Comparacio´n de la intensidad del consumo de tabaco por cohortes en Dinamarca y los Paı´ses Bajos
Objetivo Evaluar la utilidad del esquema general de la epidemia
de tabaquismo.
Me´todos Empleamos la mortalidad por ca´ncer pulmonar como
indicador de la intensidad del consumo de tabaco, pero utilizamos
un modelo de cohortes por edades para incorporar los efectos
prolongados y acumulados.
Resultados Los varones neerlandeses presentan ma´s riesgos que
los varones daneses, pero los riesgos para las cohortes jo´venes han
disminuido ma´s ra´pidamente que los de las de mayor edad. Las
mujeres danesas presentan un riesgo equivalente aproximada-
mente al doble que el de las neerlandesas, y en los dos paı´ses esta´n
aumentando los riesgos para las cohortes ma´s jo´venes. La
epidemia de tabaquismo comenzo´ casi al mismo tiempo en
Dinamarca y en los Paı´ses Bajos. Los hombres neerlandeses, sin
embargo, parecen haber fumado ma´s, pero tambie´n haber
abandonado ma´s ra´pidamente el ha´bito, que los daneses. Las
mujeres danesas adquirieron el ha´bito de fumar ma´s ra´pidamente
que las neerlandesas.
Conclusio´n Dentro del esquema general de la epidemia de
tabaquismo, las diferencias tocantes al momento de la adquisicio´n
del ha´bito y a la intensidad de e´ste pueden dar lugar a grandes
diferencias entre los paı´ses. A efectos de la evaluacio´n de los
riesgos relacionados con el tabaco, proyecciones incluidas, es
preciso adaptar el esquema de la epidemia a las caracterı´sticas de
la poblacio´n estudiada.
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